华熙生物：控股股东增持金额超过区间下限 增持计划尚未实施完毕

Core Viewpoint - Huaxi Bio (688363.SH) has announced a share buyback plan, with Huaxi Xinyu increasing its stake in the company through centralized bidding on the Shanghai Stock Exchange, indicating strong confidence in the company's future performance [1] Summary by Relevant Categories Share Buyback Details - As of September 5, 2025, Huaxi Xinyu has cumulatively increased its holdings by 3.4969 million shares, representing 0.73% of the company's total share capital [1] - The total amount spent on this buyback is RMB 201 million, exceeding the lower limit of the planned buyback range of RMB 200 million [1] - The buyback plan has not yet been fully implemented [1]